VivoSeq
Other

Anakinra

0

Pipeline Programs↗

5

Active Trials↗

0

Companies Involved↗

Anakinra is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

9

clinical trials

Completed4 · 44%
Active, not recruiting2 · 22%
Not yet recruiting2 · 22%
Recruiting1 · 11%

Clinical Trials

Trial Activity

9 trials

Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants
Recruiting·MMonash Medical Centre·Phase 2·NCT07254000·24 enrolled
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
Active, not recruiting·SSwedish Orphan Biovitrum·Phase 3·NCT05814159·15 enrolled
Anakinra for Preterm Infants Pilot
Active, not recruiting·MMonash Medical Centre·Phase 1/2·NCT05280340·25 enrolled
Non Inferiority KawasakI Trial With Anakinra
Not yet recruiting·MMeyer Children's Hospital IRCCS·Phase 4·NCT06697431·38 enrolled
Pre-emptive Anakinra for Cytokine Event Reduction
Not yet recruiting·—·Phase 1/2·NCT06703216·24 enrolled
Anakinra to Prevent Post-infarction Remodeling
Completed·VVirginia Commonwealth University·Phase 3·NCT00789724·10 enrolled
Anakinra to Prevent Adverse Post-infarction Remodeling (2)
Completed·VVirginia Commonwealth University·Phase 2·NCT01175018·30 enrolled
Open-label Study of Anakinra in MPS III
Completed·—·Phase 1/2·NCT04018755·24 enrolled
Anakinra for Behcet s Disease
Completed·National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)·Phase 1/2·NCT01441076·6 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)